Anni Aggerholm
0000-0002-8915-0122
Aarhus University Hospital
31 papers found
Refreshing results…
Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation
Measurable Residual Disease Monitoring of SPAG6, ST18, PRAME, and XAGE1A Expression in Peripheral Blood May Detect Imminent Relapse in Childhood Acute Myeloid Leukemia
GC bias affects genomic and metagenomic reconstructions, underrepresenting GC-poor organisms
Skewed ratio between type 1 and type 2 calreticulin mutations in essential thrombocytosis patients with concomitant Janus kinase 2 V617F mutation
Systematic evaluation of signal-to-noise ratio in variant detection from single cell genome multiple displacement amplification and exome sequencing
Congenital hypoplastic bone marrow failure associated with a de novo partial deletion of the MECOM gene at 3q26.2
Distinguishing myelofibrosis from polycythemia vera and essential thrombocythemia: The utility of enumerating circulating stem cells with aberrant hMICL expression by flow cytometry
Differential expression levels and methylation status of ROBO1 in mantle cell lymphoma and chronic lymphocytic leukaemia
Persistence of DNMT3A mutations at long-term remission in adult patients with AML
Delineation of known and new transcript variants of the SETMAR (Metnase) gene and the expression profile in hematologic neoplasms
A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR
Extreme hyperleukocytosis in a pediatric T-ALL patient with a rare translocation, t(7;19)(q35;p13), and submicroscopic deletions at 4q25, 7q33 and 10q23☆
Characterization and prognostic significance of mitochondrial DNA variations in acute myeloid leukemia
Diagnostic and Molecular Genetic Challenges in Male Incontinentia Pigmenti: A Case Report
Genetic and epigenetic similarities and differences between childhood and adult AML
Maintenance treatment with azacytidine for patients with high‐risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy
The combined expression of HOXA4 and MEIS1 is an independent prognostic factor in patients with AML
Pre-Screening HIV-1 Reverse Transcriptase Resistance Mutations in Subtype B Patients Using a Novel Multiplex Primer Extension Assay
Role of mitogen‐activated protein kinases, nuclear factor‐κB, and interferon regulatory factor 3 in Toll‐like receptor 4‐mediated activation of HIV long terminal repeat
Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia
Missing publications? Search for publications with a matching author name.